| scholarly article | Q13442814 |
| P2093 | author name string | Wei Li | |
| K W Michael Siu | |||
| Alexander D Romaschin | |||
| Leroi V DeSouza | |||
| Terence J Colgan | |||
| Marjorie S Minkoff | |||
| Adrian M Taylor | |||
| P433 | issue | 8 | |
| P304 | page(s) | 3525-3534 | |
| P577 | publication date | 2008-07-17 | |
| P1433 | published in | Journal of Proteome Research | Q3186939 |
| P1476 | title | Multiple reaction monitoring of mTRAQ-labeled peptides enables absolute quantification of endogenous levels of a potential cancer marker in cancerous and normal endometrial tissues | |
| P478 | volume | 7 |
| Q37651691 | A Timely Shift from Shotgun to Targeted Proteomics and How It Can Be Groundbreaking for Cancer Research. |
| Q33540915 | A comparison of the accuracy of iTRAQ quantification by nLC-ESI MSMS and nLC-MALDI MSMS methods |
| Q38713341 | A large-scale targeted proteomics assay resource based on an in vitro human proteome. |
| Q36031629 | Advancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics |
| Q88405035 | An Internal Standard for Assessing Phosphopeptide Recovery from Metal Ion/Oxide Enrichment Strategies |
| Q34377738 | An accurate proteomic quantification method: fluorescence labeling absolute quantification (FLAQ) using multidimensional liquid chromatography and tandem mass spectrometry |
| Q37997372 | An insight into iTRAQ: where do we stand now? |
| Q34079059 | Analysis of Staphylococcus enterotoxin B using differential isotopic tags and liquid chromatography quadrupole ion trap mass spectrometry |
| Q34671360 | Analysis of the formalin-fixed paraffin-embedded tissue proteome: pitfalls, challenges, and future prospectives. |
| Q51113485 | Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer. |
| Q26852271 | Applications of targeted proteomics in systems biology and translational medicine |
| Q38102992 | Arabidopsis peroxisome proteomics |
| Q38778051 | Biomarker discovery by proteomics-based approaches for early detection and personalized medicine in colorectal cancer |
| Q36956324 | Biomarker discovery in mass spectrometry-based urinary proteomics |
| Q55347431 | Cell-free synthesis of stable isotope-labeled internal standards for targeted quantitative proteomics. |
| Q37293078 | Current affairs in quantitative targeted proteomics: multiple reaction monitoring-mass spectrometry |
| Q28547212 | Custom 4-Plex DiLeu Isobaric Labels Enable Relative Quantification of Urinary Proteins in Men with Lower Urinary Tract Symptoms (LUTS) |
| Q36816520 | Development and characterization of novel 8-plex DiLeu isobaric labels for quantitative proteomics and peptidomics |
| Q37619708 | Development of a sequential workflow based on LC-PRM for the verification of endometrial cancer protein biomarkers in uterine aspirate samples. |
| Q33917896 | Food allergen detection by mass spectrometry: the role of systems biology |
| Q61813107 | HOTMAQ: A Multiplexed Absolute Quantification Method for Targeted Proteomics |
| Q92334964 | High-Resolution Enabled 5-plex Mass Defect-Based N, N-Dimethyl Leucine Tags for Quantitative Proteomics |
| Q43134357 | High-resolution enabled 12-plex DiLeu isobaric tags for quantitative proteomics |
| Q33827039 | High-throughput peptide quantification using mTRAQ reagent triplex |
| Q39539278 | Identification of proteins secreted by head and neck cancer cell lines using LC-MS/MS: Strategy for discovery of candidate serological biomarkers |
| Q33397208 | Implementation of a data repository-driven approach for targeted proteomics experiments by multiple reaction monitoring |
| Q37023610 | Increasing the multiplexing capacity of TMTs using reporter ion isotopologues with isobaric masses |
| Q34616855 | Index-ion triggered MS2 ion quantification: a novel proteomics approach for reproducible detection and quantification of targeted proteins in complex mixtures |
| Q34553406 | Influence of histatin 5 on Candida albicans mitochondrial protein expression assessed by quantitative mass spectrometry |
| Q37763937 | Integrative oncoproteomics strategies for anticancer drug discovery |
| Q34310103 | Internal standard strategies for relative and absolute quantitation of peptides in biological matrices by liquid chromatography tandem mass spectrometry |
| Q42589927 | Lesson from the stoichiometry determination of the cohesin complex: a short protease mediated elution increases the recovery from cross-linked antibody-conjugated beads |
| Q48260815 | Mass Defect-Based Dimethyl Pyrimidinyl Ornithine (DiPyrO) Tags for Multiplex Quantitative Proteomics. |
| Q54294820 | Mass spectral enhanced detection of Ubls using SWATH acquisition: MEDUSA--simultaneous quantification of SUMO and ubiquitin-derived isopeptides. |
| Q38198753 | Mass spectrometry-based plasma proteomics: state of the art and future outlook |
| Q37791243 | Mass spectrometry-based proteomics in biomedical research: emerging technologies and future strategies |
| Q38217990 | Mass spectrometry-driven phosphoproteomics: patterning the systems biology mosaic |
| Q37800056 | Mass spectrometry‐based clinical proteomics: Head‐and‐neck cancer biomarkers and drug‐targets discovery |
| Q34544173 | Metal labeling for accurate multiplexed peptide quantification via matrix-assisted laser desorption/ionization mass spectrometry. |
| Q44171931 | Metal-tag labeling coupled with multiple reaction monitoring-mass spectrometry for absolute quantitation of proteins. |
| Q30387118 | Multiplex N-terminome analysis of MMP-2 and MMP-9 substrate degradomes by iTRAQ-TAILS quantitative proteomics |
| Q37480226 | Neucode Labels for Multiplexed, Absolute Protein Quantification |
| Q47353598 | New ionization tags based on the structure of the 5-azoniaspiro[4.4]nonyl tag for a sensitive peptide sequencing by mass spectrometry. |
| Q34772405 | Novel isotopic N,N-dimethyl leucine (iDiLeu) reagents enable absolute quantification of peptides and proteins using a standard curve approach |
| Q34150462 | Novel mass spectrometric method for phosphorylation quantification using cerium oxide nanoparticles and tandem mass tags |
| Q37788627 | Overview of Quantitative LC-MS Techniques for Proteomics and Activitomics |
| Q36406428 | Overview: the maturing of proteomics in cardiovascular research |
| Q41958094 | Peptide dimethylation: fragmentation control via distancing the dimethylamino group |
| Q37238671 | Proteomic analysis revealed the altered tear protein profile in a rabbit model of Sjögren's syndrome-associated dry eye. |
| Q33591828 | Proteomic expression profiling of Haemophilus influenzae grown in pooled human sputum from adults with chronic obstructive pulmonary disease reveal antioxidant and stress responses |
| Q38626386 | Proteomics of endometrial cancer diagnosis, treatment, and prognosis. |
| Q38287636 | Quantitation with chemical tagging reagents in biomarker studies |
| Q38048726 | Quantitative mass spectrometry for colorectal cancer proteomics |
| Q38024637 | Quantitative mass spectrometry in proteomics: critical review update from 2007 to the present |
| Q36907471 | Quantitative multiple reaction monitoring of peptide abundance introduced via a capillary zone electrophoresis-electrospray interface |
| Q38483307 | Quantitative proteome analysis of age-related changes in mouse gastrocnemius muscle using mTRAQ. |
| Q31039257 | Quantitative proteomics of complex mixtures. |
| Q35194600 | Rapid verification of candidate serological biomarkers using gel-based, label-free multiple reaction monitoring |
| Q36617725 | Relative quantification of biomarkers using mixed-isotope labeling coupled with MS. |
| Q39651203 | Secretome-Based Identification and Characterization of Potential Biomarkers in Thyroid Cancer |
| Q34002689 | Selected reaction monitoring (SRM) mass spectrometry without isotope labeling can be used for rapid protein quantification |
| Q37851918 | Selected reaction monitoring applied to proteomics. |
| Q34279143 | Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions |
| Q37803137 | Targeted proteomics by selected reaction monitoring mass spectrometry: applications to systems biology and biomarker discovery |
| Q38604366 | Targeted proteomics of solid cancers: from quantification of known biomarkers towards reading the digital proteome maps |
| Q35815142 | Targeted proteomics: a bridge between discovery and validation |
| Q33897503 | The Human Proteome Organization Chromosome 6 Consortium: integrating chromosome-centric and biology/disease driven strategies |
| Q36926612 | The cancer secretome: a reservoir of biomarkers |
| Q36771005 | The clinical impact of recent advances in LC-MS for cancer biomarker discovery and verification |
| Q27010380 | The use of neuroproteomics in drug abuse research |
| Q37972865 | Towards clinical applications of selected reaction monitoring for plasma protein biomarker studies |
| Q64256124 | Trends in the Design of New Isobaric Labeling Reagents for Quantitative Proteomics |
| Q36209046 | iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics |
| Q33641661 | mTRAQ-based quantification of potential endometrial carcinoma biomarkers from archived formalin-fixed paraffin-embedded tissues |
Search more.